A2b adenosine receptor antagonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 487/04 (2006.01) A61K 31/519 (2006.01) A61P 11/06 (2006.01)

Patent

CA 2544193

Disclosed are novel compounds that are A2B adenosine receptor antagonists having the following structure (I) wherein R1 and R2 are independently chosen from hydrogen, optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted aryl, and optionally substituted heteroaryl, and R4 is an optionally substituted heteroaryl moiety. The compounds of the invention are useful for treating various disease states, including asthma, chronic obstructive pulmonary disorder, pulmonary inflammation, emphysema, diabetic disorders, inflammatory gastrointestinal tract disorders, immunological/inflammatory disorders, cardiovascular diseases, neurological disorders, and diseases related to angiogenesis.

L'invention concerne de nouveaux composés constituant des antagonistes du récepteur de l'adénosine A2B représentés par la structure suivante (I) dans laquelle R?1¿ et R?2¿ sont indépendamment sélectionnés parmi l'hydrogène, un alkyle éventuellement substitué, un cycloalkyle éventuellement substitué, un aryle éventuellement substitué, et un hétéroaryle éventuellement substitué, et R?4¿ est un fragment hétéroaryle éventuellement substitué. Les composés de l'invention sont utilisés dans le traitement de divers états pathologiques, y compris l'asthme, la bronchopneumopathie chronique obstructive, une inflammation pulmonaire, l'emphysème, les troubles diabétiques, les troubles inflammatoires du tractus gastro-intestinal, les troubles immunologiques/inflammatoires, les maladies cardiovasculaires, les troubles neurologiques, et les maladies associées à l'angiogenèse.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

A2b adenosine receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with A2b adenosine receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A2b adenosine receptor antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1783562

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.